Before The Bell: Pharma's New Blockbuster; Bank-Lending Drought
Big Pharma companies are looking for the next blockbuster drug. BIS warns of further credit crunch extending into 2008.
WSJ reports big pharma companies are trying to find a new blockbuster drug in the global blood-thinning market. With at least five next-generation bloodthinners in advanced testing, these drugs could reach the market as early as 2009. The big pharma companies such as Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY), Pfizer (PFE), and Eli Lilly (LLY) are all racing to find a drug for Atrial fibrillation, a heart condition that affects 5.5 mln people worldwide and requires daily therapy for the rest of the patient's life. Analysts estimate the market for these drugs could exceed $10 bln by 2015. Todd mentioned the pharma space in his Minyan Mailbag.
From the Bull Pen: Todd said he believed pharma will relatively outperform going forward. Bulls may see a play in JNJ, sell-stops below $66.50. Bulls may also play the broader iShares Pharma ETF (IHE), sell-stops below $53.92.
From the Bear Cave: Bears may see a down-side play in Pfizer (PFE), believing the stock is following a downtrend line from its June high; buy-stops placed above $24.80.
Bloomberg reports the Bank of International Settlements (BIS) says the global credit crunch could extend beyond the first quarter of 2008. The BIS said in its latest survey that models using derivatives based on money-market rates show investors expect a persistent lack of liquidity and remained concerned about counterparty risk. Further, one analyst warned that this lack of bank liquidity has become a more serious problem than subprime "though both are correlated." Counterparty risk is evident in Professor Mike Mish Shedlock's Sell Now, Ask Questions Later.
From the Bull Pen: Bulls may see long-side plays in consumer non-durables in a slowing economy. Procter & Gamble (PG) may be an option; near-term sell-stops below $72.00.
From the Bear Cave: Bears can look to the financials for a downside play should liquidity concerns continue. Bank of America (BAC) may be a reasonable option with an entry at $47.30, which resembles a 50% retracement line from the October high. Buy-stops may be set above.
Click on Minyanville's Stocks To Watch for more company-specific ideas.
Quick Check Around the World
Asian trading closed with the Hang Seng -1.18%, Nikkei -0.20%, Sensex -0.18%, Taiwan -1.43% and Shanghai +1.38%.
A quick look towards Europe finds the CAC +0.25%, DAX +0.30%, FTSE +0.01%, ATX -0.53%, Swiss Mkt. +0.60% and Stockholm +0.31%.
A Look At Commodities
Crude oil is up this morning 0.29 to 88.57. Gold is higher 7.80 to 808.00. Silver is up 0.09 to 14.59, and copper is down -4.3 to 308.30.
As of 8:45 AM, S&P futures are up by +5.50 points, and Nasdaq futures are higher by 7.00 points.
On the Radar
10:00 Pending Home Sales
Click here for the full trading radar.
Happy Monday, everyone! Good luck today!
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.
Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Daily Recap Newsletter